Vaspin, an insulin-sensitizing adipokine, has been associated with type 2 diabetes (T2D).
The present study aimed to investigate the distribution of genotypes and high-risk alleles of …

Background In recent years, the role of vaspin as an insulin-sensitizer has been studied
widely. This is the investigation that examined the association of vaspin polymorphism …

Introduction: Globally, the incidence of obesity is rising rapidly, not only in industrialized
nations but also in developing countries consistent with which higher vaspin serum …

Background Vaspin is an adipokine that is potentially linking obesity, insulin resistance,
metabolic syndrome and type-2 diabetes. Aim The present study aimed to investigate the …

Aim Vaspin is an adipokine separated from visceral fat tissues of obese diabetic rats. This
study was to investigate the association between vaspin rs2236242 gene polymorphism and …

Objective: Visceral adipose tissue-derived serine protease inhibitor (vaspin) is an adipokine
potentially linking obesity, insulin resistance and type 2 diabetes. Here, we searched for …

Recently, vaspin was identified as an adipokine with insulin-sensitizing effects, which is
predominantly secreted from visceral adipose tissue in a rat model of type 2 diabetes. In this …

Background Elevated circulating vaspin levels is linked with type 2 diabetes mellitus (T2DM)
and obesity. The genetic basis of the association between vaspin rs2236242 and T2DM and …

Coronary artery disease (CAD) is the primary cause of death worldwide. Vaspin was a
recently described adipokine, playing a protective role in many metabolic and …

Vaspin is an adipokines with insulin sensitizing effect. The regulation of serum vaspin levels
in humans with obesity and T2DM is still unclear. Investigate the circulating level of vaspin in …